ROIVW (Roivant Sciences) Retained Earnings: $-501.81 Mil (As of Mar. 2026)


ROIVW Roivant Sciences Ltd ROIVW
51 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences Retained Earnings?

Roivant Sciences ROIVW -3.85% 51 Retained Earnings is $-501.81 Mil as of Mar. 2026. GuruFocus rates ROIVW with a GF Score™ of 51/100. The stock has 7 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Roivant Sciences's retained earnings for the quarter that ended in Mar. 2026 was $-501.81 Mil.

Roivant Sciences's quarterly retained earnings declined from Sep. 2025 ($-429.11 Mil) to Dec. 2025 ($-695.00 Mil) but then increased from Dec. 2025 ($-695.00 Mil) to Mar. 2026 ($-501.81 Mil).

Roivant Sciences's annual retained earnings declined from Mar. 2024 ($576.17 Mil) to Mar. 2025 ($116.06 Mil) and declined from Mar. 2025 ($116.06 Mil) to Mar. 2026 ($-501.81 Mil).


Roivant Sciences  (NAS:ROIVW) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Roivant Sciences Retained Earnings Historical Data

* Premium members only.

The historical data trend for Roivant Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences Retained Earnings Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Retained Earnings
Get a 7-Day Free Trial -2,763.72 -3,772.75 576.17 116.06 -501.81

Roivant Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.06 -315.59 -429.11 -695.00 -501.81
ROIVW
51GF Score
Roivant Sciences Ltd ROIVW
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roivant Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-501.81 Mil mean?
Roivant Sciences (ROIVW) has a Retained Earnings of $-501.81 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Roivant Sciences and its competitors.
Is Roivant Sciences' Retained Earnings too high?
Roivant Sciences' current Retained Earnings is $-501.81 Mil. Overall, Roivant Sciences has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Roivant Sciences' Retained Earnings compare to RPRX and BNTX?
Roivant Sciences' Retained Earnings of $-501.81 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Roivant Sciences and its competitors. Roivant Sciences's current Retained Earnings is $-501.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roivant Sciences stock overvalued right now?
Roivant Sciences (ROIVW) has a current Retained Earnings of $-501.81 Mil. The current Retained Earnings is $-501.81 Mil. Roivant Sciences' overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Roivant Sciences (ROIVW), the current Retained Earnings is $-501.81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
51GF Score

Get the complete analysis for ROIVW

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price